The Management Board of Fundusz Hipoteczny DOM S.A. presents a summary of subscription for series F shares: br> br> 1) Subscription start and end date: br> subscription start date: August 11, 2017, br> subscription end date: August 25, 2017. , br> 2) Share allocation date: br> 25 August 2017 br> 3) Number of subscribed shares: br> 2.010.000 series F shares br> 4) Reduction rate in individual tranches br> Not applicable. br> 5) Number of shares that were allotted as part of the subscription: br> 2.010.000 series F shares br> 6) Price at which shares were subscribed: br> PLN 4.6 per share . br> 6a) description of the method of covering the shares: br> Series F shares were taken up for cash. br> 7) Number of persons who subscribed for shares subscribed for in individual tranches: br> - 2 persons br> 8) Number of persons to whom shares were allocated as part of the subscription carried out in individual tranches: br> - 2 persons br> 9) The names (companies) of underwriters who subscribed for shares under the underwriting agreements: < / br> sub-issuers did not participate in the subscription of series F shares. br> 10) The total amount of costs that were included in the share issue costs of series F amounts to PLN 52,699 net, including: br> - costs of preparing and conducting the offer : PLN 38,869 net, br> - underwriter's expenses: PLN 0 net, br> - costs of preparing an information document, including consultancy costs: PLN 13,500 net, br> - offer promotion costs: PLN 0 net. < / br> Share issue costs according to art. 36 par. 2b of the Accounting Act, incurred at the increase of share capital, reduce the supplementary capital to the amount of surplus of issue over the par value of shares ("agio") and the remaining part is included in financial costs. Br> Legal basis: § 4 para. 1 of Appendix No. 3 to the Alternative Regulations of the Trading System - "Current and Periodic Information provided in the Alternative Trading System on the NewConnect market". Br>
Source: company website, investor relations, current and periodic reports.